Caseware UK (AP4) 2024.0.164 2024.0.164 2025-04-30 2025-04-30 2 false The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-05-01 No description of principal activity false false SC805527 2024-04-30 SC805527 2024-05-01 2025-04-30 SC805527 2023-04-06 2024-04-02 SC805527 2025-04-30 SC805527 c:Director1 2024-05-01 2025-04-30 SC805527 d:CurrentFinancialInstruments 2025-04-30 SC805527 c:Micro-entities 2024-05-01 2025-04-30 SC805527 c:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 SC805527 c:FullAccounts 2024-05-01 2025-04-30 SC805527 c:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 SC805527 e:PoundSterling 2024-05-01 2025-04-30 iso4217:GBP xbrli:pure

Registered number: SC805527 BMS SURGICAL LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 30 APRIL 2025
BMS SURGICAL LIMITED REGISTERED NUMBER: SC805527 BALANCE SHEET AS AT 30 APRIL 2025
|  | 2025
|  | £
Fixed assets |  | 3,975
Current assets | 24,022 |
Creditors: amounts falling due within one year | (6,508) |
Net current assets |  | 17,514
Total assets less current liabilities |  | 21,489
Net assets |  | 21,489
Capital and reserves |  | 21,489
Notes
General information
BMS Surgical Limited is a private company limited by shares incorporated in Scotland. The registered office is 6 St. Colme Street, Edinburgh, EH3 6AD.
Average number of employees
The average monthly number of employees, including directors, during the year was 2. The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 8 October 2025.
Benjamin Mark Stutchfield
Director
Page 1